Tamoxifen, Vitamin D3 and their combination exerted their anti-cancer activity by similarly decreasing gene expression levels for P53 and BCL2. The proteins were involved in cell cycle progression and apoptosis respectively. This evidence concerns the gene TP53 and cancer.